Skip to main content
. Author manuscript; available in PMC: 2022 Mar 24.
Published in final edited form as: Exp Clin Psychopharmacol. 2021 Jun 10;29(5):555–565. doi: 10.1037/pha0000503

Figure 2:

Figure 2:

Remote Breathalyzer Results

Note. Abstinence and individual sample collection rate results from the thrice-daily remote breathalyzer assessments during the Treatment phase. Percent days abstinent was significantly higher in the Contingent group (top), and the collection rate was similarly high in both groups (bottom).